Journal
DIAGNOSTICS
Volume 12, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics12112744
Keywords
Giardia duodenalis; proteomics; vaccine and drug development; virulence; pathogenicity mechanism; PTMs
Categories
Funding
- Higher Institution Centre of Excellence (HICoE) Grant Scheme [311/CIPPM/4401005]
- Malaysian Ministry of Higher Education through Fundamental Research Grant (FRGS) Scheme [FRGS/1/2018/SKK12/USM/02/1]
Ask authors/readers for more resources
This article reviews the applications of proteomics in studying G. duodenalis and proposes future directions for research.
Giardia duodenalis remains a neglected tropical disease. A key feature of the sustained transmission of Giardia is the ability to form environmentally resistant cysts. For the last 38 years, proteomics has been utilised to study various aspects of the parasite across different life cycle stages. Thirty-one articles have been published in PubMed from 2012 to 2022 related to the proteomics of G. duodenalis. Currently, mass spectrometry with LC-MS/MS and MALDI-TOF/TOF has been commonly utilised in proteomic analyses of Giardia, which enables researchers to determine potential candidates for diagnostic biomarkers as well as vaccine and drug targets, in addition to allowing them to investigate the virulence of giardiasis, the pathogenicity mechanisms of G. duodenalis, and the post-translational modifications of Giardia proteins throughout encystation. Over the last decade, valuable information from proteomics analyses of G. duodenalis has been discovered in terms of the pathogenesis and virulence of Giardia, which may provide guidance for the development of better means with which to prevent and reduce the impacts of giardiasis. Nonetheless, there is room for improving proteomics analyses of G. duodenalis, since genomic sequences for additional assemblages of Giardia have uncovered previously unknown proteins associated with the Giardia proteome. Therefore, this paper aims to review the applications of proteomics for the characterisation of G. duodenalis pathogenicity and the discovery of novel vaccine as well as drug targets, in addition to proposing some general directions for future Giardia proteomic research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available